EPISODE · Jun 27, 2025 · 13 MIN
Raising Awareness and Advancing Research: Andrew Rosen on Fighting Ataxia Through Community and Science
from Mission Matters Business Podcast with Adam Torres · host Adam Torres
In this Mission Matters episode, Adam Torres interviews Andrew Rosen, CEO of the National Ataxia Foundation, as part of the Milken Global Conference Series. Rosen shares the challenges of diagnosing and treating ataxia a rare, inherited neurodegenerative disorder and how his foundation is funding critical research, supporting patients and families, and pushing for greater awareness and federal support. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
In this Mission Matters episode, Adam Torres interviews Andrew Rosen, CEO of the National Ataxia Foundation, as part of the Milken Global Conference Series. Rosen shares the challenges of diagnosing and treating ataxia a rare, inherited neurodegenerative disorder and how his foundation is funding critical research, supporting patients and families, and pushing for greater awareness and federal support. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Raising Awareness and Advancing Research: Andrew Rosen on Fighting Ataxia Through Community and Science
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m